TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
Stocks in this Quantisnow insightHealth Care
Historical context for TMDX
Across the 7 sessions after earlier TMDX headlines, the stock closed higher 3 times and lower 4 times, with a median move of 2.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TMDX | SPY |
|---|---|---|---|
| Jan 12, 2026 | TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts | -1.8% | +0.2% |
| Dec 31, 2025 | TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference | -0.2% | -0.7% |
| Dec 26, 2025 | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | -2.2% | -0.0% |
| Nov 19, 2025 | TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference | +14.0% | +0.4% |
| Nov 3, 2025 | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | -5.2% | +0.2% |
| Oct 30, 2025 | TransMedics Reports Third Quarter 2025 Financial Results | +1.1% | -1.1% |
Keep researching TMDX
- TMDX insider tradesEvery buy and sale reported by TransMedics Group Inc. officers, directors and large holders.
- TMDX earnings historyPast TransMedics Group Inc. earnings releases, newest first.
- TMDX financial statementsRevenue, profit, cash flow and balance sheet from TransMedics Group Inc.'s SEC filings.
Quantisnow market dataNASDAQ
TMDX
TransMedics Group Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2019
Get push alerts for TMDX
Full TMDX profile on Quantisnow Follow TMDX and get a push notification the moment its next story breaks.